Comment on ‘Predictive factors for eczematous eruptions and candidiasis during anti-interleukin-17 treatment in patients with psoriasis’: bimekizumab-induced spongiotic dermatitis
A patient with hidradenitis suppurativa developed a progressive eczematous drug reaction to bimekizumab. The eczematous dermatitis presented in a unique distribution primarily in areas of prior hidradenitis suppurativa. We discuss our management approach, which could help clinicians who are treating similar patients.
Authors
- Jason Cohen (ORCID: https://orcid.org/0000-0002-7696-0839)
- Naveed Sami (ORCID: https://orcid.org/0000-0003-4141-9468)
- Ashley N Houff (ORCID: https://orcid.org/0000-0002-5522-0137)
Institutions
- University of Central Florida (US)
- Orlando Health (US)
- White Plains Hospital (US)
- Florida College (US)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1093/ced/llaf425
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00